Anaphylactic Reaction to Dulaglutide: A Glucagon Like Peptide- 1 Receptor Agonist

Introduction: The development of Glucagon like peptide-1 (GLP-1) receptors agonists represents an important advancement in the management of type 2 diabetes. The long-acting GLP-1 receptor agonists improve glycemic control, promote weight loss. Anaphylaxis to GLP-1 receptor agonists and mainly Dulag...

Descripción completa

Detalles Bibliográficos
Autores principales: Quadri, Hamza, Ataallah, Basma, Haggerty, Gregory
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Diabetes Mellitus and Glucose Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090007/
http://dx.doi.org/10.1210/jendso/bvab048.748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090007/
http://dx.doi.org/10.1210/jendso/bvab048.748

Ejemplares similares